Login / Signup

Rationale and design of the CAROLINA® - cognition substudy: a randomised controlled trial on cognitive outcomes of linagliptin versus glimepiride in patients with type 2 diabetes mellitus.

Geert Jan BiesselsJolien JanssenEsther van den BergBernard ZinmanMark A EspelandMichaela MattheusOdd Erik Johansennull null
Published in: BMC neurology (2018)
ClinicalTrials.gov Identifier: NCT 01243424 .
Keyphrases
  • mild cognitive impairment
  • white matter
  • metabolic syndrome
  • multiple sclerosis
  • skeletal muscle
  • weight loss